The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group.

Saudi J Gastroenterol · 2025 · PMC11804962 · PMID 39291466

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Glucocorticoid-free remission data analysis from KSUMC revealed a decreasing trend in percentage over the follow-up period, with a particularly intriguing spike at 12 months.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.